2022 International Congress Archives - Page 117 of 153

Qualification of Digital Endpoints of Function in Healthy Volunteers for Use in a Decentralized Natural History Study in Genetic Parkinson’s Disease (PD)

S. Sankaranarayanan, C. Tomkins-Lane, D. Singamsetty, G. Yahalom, N. France, M. Maurer, C. Barlow (South San Francisco, USA)
Quality of Life and Motor Outcomes for Parkinson’s Disease Patients 12 Months After Deep Brain Stimulation in China

Y. Zhang, L. Chen, B. Sun, X. Wang, J. Wang, J. Wang, J. Woods, K. Stromberg, H. Shang (Chengdu, China)
Quality of life and patient reported outcomes with subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 BeyoND study

W. Poewe, F. Stocchi, L. Adar, T. Yardeni, A. Espay (Innsbruck, Austria)
Quality of life changes after subthalamic stimulation for Parkinson’s disease depend on nonmotor and motor symptoms clusters

L. Braun, S. Jost, M. Silverdale, A. Rizos, M. Santos Ghilardi, R. Cury, P. Loehrer, C. Nimsky, K. Ashkan, A. Sauerbier, A. Gronostay, G. Fink, M. Barbe, J. Evans, V. Visser-Vandewalle, E. Fonoff, A. Antonini, L. Timmermann, P. Martinez-Martin, K. Chaudhuri, H. Dafsari (Cologne, Germany)
Quality of Life in African American and White Parkinson’s Disease Patients

D. Hall, S. Anderson, G. Stebbins, L. Barnes, M. Bailey, L. Shulman (Chicago, USA)
Quantitative susceptibility mapping of basal ganglia and related structures: correlation with disease severity in Progressive Supranuclear Palsy

S. Krishnan, S. George, S. Raghavan, B. Thomas, J. Thulaseedharan, D. Puthenveedu, A. Kishore (Thiruvananthapuram, India)
Quantity detection of Substantia nigra hyperechogenicity based on digital image analysis for diagnosing Parkinson’s disease

L. Gao, Z. Xue, X. Zhou (Nanchang, China)
Racial Differences in Essential Tremor

F. Jamal, I. Noorbhai, G. Jackson, A. Sarwar ()
Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study of Ecopipam in Children and Adolescents with Tourette Syndrome

A. Mahableshwarkar, J. Dubow, T. Cunniff, S. Wanaski (Chicago, USA)
Rapid onset of good ON time and improvement in motor-state stability in aPD patients after treatment with continuous subcutaneous foslevodopa/foscarbidopa

R. Pahwa, M. Soileau, D. Standaert, V. Fung, T. Kimber, I. Malaty, A. Merola, A. Epstein, C. Yan, A. Alobaidi, A. Shewale, N. Fisseha, A. Jeong, M. Facheris, P. Kukreja, J. Zamudio, J. Aldred (Kansas City, USA)